Immunomedics, Inc. (IMMU): Stock Offering News

IMMU – Prices 11.5 mln common stock offering at $24.00/share.

Key Facts Surrounding This News Item

  • IMMU had a POWR Rating of B (Buy) coming into today.
  • IMMU was 1.97% above its 10-Day Moving Average coming into today.
  • IMMU was 8.01% above its 20-Day Moving Average coming into today.
  • IMMU was 27.42% above its 50-Day Moving Average coming into today.
  • IMMU was 37.50% above its 100-Day Moving Average coming into today.
  • IMMU was 62.17% above its 200-Day Moving Average coming into today.
  • IMMU had returned +51.24% year-to-date leading up to today’s news, versus a +4.94% return from the benchmark S&P 500 during the same period.

More Info About Immunomedics, Inc. (IMMU)

Immunomedics, Inc. focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases. The company was founded in 1982 and is based in Morris Plains, New Jersey. View our full IMMU ticker page with ratings, news, and more.

Try Premium Today!

Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

IMMU at a Glance

IMMU Current POWR Rating™
Overall POWR Rating™
IMMU Current Price $21.35 3.59%
More IMMU Ratings, Data, and News

IMMU Price Reaction

The day of this event (Jun. 13, 2018)
IMMU Closing Price$24.33 0.45%
IMMU Volume10,664,500
306.39% from avg
Leading up to this event
IMMU 1-mo returnN/A%
After this event
IMMU 1-day return1.83%
IMMU 3-day return1.45%
IMMU 5-day return3.59%

IMMU Price Chart

More Immunomedics, Inc. (IMMU) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All IMMU News
Page generated in 0.9835 seconds.